sexual addiction disorder, stimulant use disorder. Other sexual dysfunction not due to a substance or known physiological condition
Conditions
Interventions
Intervention 1: Intervention group1: People with sexual addiction disorder
According to the handbook for guideline development (World Health Organization, 2012) and based on literature review, the clinical guide for the treatment of sexual addiction disorder in the form of 1
For the control group, the placebo will be presented in the form of books and educational videos in the field of treatment of sexual addiction disorder. Intervention 4: Control group 2: People with se
For the control group, the placebo will be presented in the form of books and educational videos in the field of treatment of sexual addiction disorder.
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: receiving a diagnosis of stimulant use disorder receiving a diagnosis of sexual addiction disorder
Exclusion criteria
Exclusion criteria: Existence of mental retardation Symptoms of psychosis Bipolar disorder Acute thoughts of suicide Opioid use Drug use Having any organic disorders such as a history of head trauma with anesthesia, seizures, brain tumors, etc., which has led to cognitive and psychological disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| People who have a score of 53 or higher in the Hypersexual Behavior Inventory. Timepoint: Measuring the score of the Hypersexual Behavior Inventory before the intervention (pre-test), after the intervention (post-test) and 2-month follow-up. Method of measurement: Hypersexual Behavior Inventory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArash Javaheri
Iran University of Medical Sciences
Outcome results
None listed